Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Currently in the UK, injectable GLP-1 receptor agonists such as semaglutide (Ozempic) and dulaglutide (Trulicity) are well-established treatments recommended by NICE (NG28) for specific indications in type 2 diabetes management, with some formulations also approved for weight management
Those interested in how retatrutide compares to semaglutide should note that newer peptides may have different stability profiles than established ones
Clin Pharmacol Drug Dev
A novel p53-inducible apoptogenic gene, PRG3, encodes a homologue of the apoptosis-inducing factor (AIF)
US$ 26.87
US$ 20.27
US$ 26.16
US$ 27.05
US$ 26.13
.webp)
US$ 24.48
